[1] |
Sakakibara S, Konno S. Endomyocardial biopsy[J]. Jpn Heart J, 1962, 3: 537-543.
|
[2] |
Weinberg M, Fell EH, Lynfield J. Diagnostic biopsy of the pericardium and myocardium[J]. AMA Arch Surg, 1958,76(5): 825-829.
|
[3] |
Caves PK, Stinson EB, Graham AF, et al. Percutaneous transvenous endomyocardial biopsy[J]. JAMA, 1973,225(3):288-291.
|
[4] |
Kawai C, Kitaura Y. New endomyocardial biopsy catheter for the left ventricle[J]. Am J Cardiol, 1977, 40(1):63-65.
|
[5] |
Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology[J].Circulation, 2007, 116(19): 2216-2233.
|
[6] |
Francis R, Lewis C. Myocardial biopsy: techniques and indications[J]. Heart, 2018, 104(11):950-958.
|
[7] |
Seferović PM, Tsutsui H, McNamara DM, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy[J]. Eur J Heart Fail,2021, 23(6): 854-871.
|
[8] |
徐希奇, 田庄, 方全, 等. 北京协和医院经皮心内膜心肌活检临床操作规范[J]. 协和医学杂志, 2021, 12(3):322-327.
|
[9] |
Porcari A, Baggio C, Fabris E, et al. Endomyocardial biopsy in the clinical context: current indications and challenging scenarios[J]. Heart Fail Rev, 2023, 28(1):123-135.
|
[10] |
Patel IJ, Rahim S, Davidson JC, et al. Society of Interventional Radiology Consensus Guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe[J]. J Vasc Interv Radiol, 2019, 30(8):1168-1184.e1.
|
[11] |
Harwani N, Chukwu E, Alvarez M, et al. Comparison of brachial vein versus internal jugular vein approach for access to the right side of the heart with or without myocardial biopsy[J]. Am J Cardiol, 2015, 116(5):740-743.
|
[12] |
Schäufele TG, Spittler R, Karagianni A, et al. Transradial left ventricular endomyocardial biopsy: assessment of safety and efficacy[J]. Clin Res Cardiol, 2015, 104(9):773-781.
|
[13] |
Thiene G, Bruneval P, Veinot J, et al. Diagnostic use of the endomyocardial biopsy: a consensus statement[J].Virchows Arch, 2013, 463(1):1-5.
|
[14] |
Holzmann M, Nicko A, Kühl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period[J]. Circulation, 2008, 118(17):1722-1728.
|
[15] |
Chimenti C, Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period[J]. Circulation, 2013, 128(14):1531-1541.
|
[16] |
Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center[J]. J Am Coll Cardiol, 1992, 19(1):43-47.
|